Canadian Yeast Specialist Lallemand Acquires Swiss Biotech Company Evolva
Lallemand Inc., a Canadian company specializing in yeast-based ingredients, has confirmed that its subsidiary Danstar Ferment AG has acquired Swiss biotech company Evolva AG. Similarly to Lallemand, Evolva is focused on researching, developing, and commercializing natural yeast-derived ingredients. The company’s products are used in several sectors, including flavors and fragrances, health ingredients, cosmetics, and health protection. The transaction was announced to the Swiss Stock Exchange on November 21, and was confirmed by shareholders of Evolva Holding — Evolva’s previous parent company — at a general meeting on December 21. The initial purchase price is CHF 20 million (US$23.5 million), though this may be adjusted. Evolva Holding may also receive a payout of up to CHF 10 million (US$11.75 million) if certain product-based sales targets are …